<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02875249</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/10/04-Q</org_study_id>
    <nct_id>NCT02875249</nct_id>
  </id_info>
  <brief_title>Intestinal Microbiome and Chemotherapy</brief_title>
  <acronym>EMAAD</acronym>
  <official_title>Chemotherapy-driven Dysbiosis in the Intestinal Microbiome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chemotherapy is commonly used as myeloablative conditioning treatment to prepare patients for
      haematopoietic stem cell transplantation (HSCT). Chemotherapy leads to several side effects,
      with gastrointestinal (GI) mucositis being one of the most frequent. Current models of GI
      mucositis pathophysiology are generally silent on the role of the intestinal microbiome.

      The aim of the study is to identify functional mechanisms by which the intestinal microbiome
      may play a key role in the pathophysiology of GI mucositis, the investigators applied high
      throughput DNA-sequencing analysis to identify microbes and microbial functions that are
      modulated following chemotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>analyze of the fecal samples using 16S ribosomal ribonucleic acid (rRNA) gene sequencing</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>analyze of the fecal samples using 16S ribosomal ribonucleic acid (rRNA) gene sequencing</measure>
    <time_frame>at day 7</time_frame>
  </primary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Diarrhea</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patients stool collection</intervention_name>
    <description>patients stool collection</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      stool of patients for bacterial analysis
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients, men and women, 18 to 65, who receive intravenous antibiotics broad spectrum
        (Tazocilline (piperacillin tazobactam) and Amiklin (amikacin)) in support of the context of
        febrile neutropenia following a autologous stem cells.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants with non-Hodgkin's lymphoma

          -  Participants receiving the same myeloablative conditioning regimen for five
             consecutive days, including high-dose Carmustine (Bis-chloroethylnitrosourea),
             Etoposide, Aracytine and Melphalan.

        Exclusion Criteria:

          -  Patients with a history of Inflammatory Bowel Diseases (IBD), exposed to probiotics,
             prebiotics or broad-spectrum antibiotics, or administered nasal-tube feeding or
             parenteral nutrition in the month prior to initiation of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Montassier, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes Univetsity Hospital</affiliation>
  </overall_official>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2016</study_first_submitted>
  <study_first_submitted_qc>August 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2016</study_first_posted>
  <last_update_submitted>August 26, 2016</last_update_submitted>
  <last_update_submitted_qc>August 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>post-antibiotic diarrhea</keyword>
  <keyword>intestinal microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

